Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Testosterone replacement for older men with sarcopenia

Trial Profile

Testosterone replacement for older men with sarcopenia

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 01 Mar 2017

At a glance

  • Drugs Testosterone (Primary)
  • Indications Hypogonadism
  • Focus Therapeutic Use
  • Acronyms TOM
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 22 Feb 2017 Status changed from completed to discontinued because of higher incidence of cardiovascular events in the testosterone arm of the trial.
    • 07 Jun 2011 Results presented at the 93rd Annual Meeting of the Endocrine Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top